Mojca Unk

Ljubljana, SI 
Ljubljana, SI 

Overview

Mojca Unk practices practicing medicine in Ljubljana, Slovenia.

Their clinical expertise encompasses Gastrointestinal Stromal Tumor, Adult Soft Tissue Sarcoma, Lung Cancer, and NUT Carcinoma.

They are actively involved in clinical research, co-authoring 23 peer reviewed articles and participating in 2 clinical trials.

Locations

Ljubljana, 1000, Slovenia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicentre Randomised Phase III Trial Comparing Atezolizumab Plus Bevacizumab and Standard Chemotherapy Versus Bevacizumab and Standard Chemotherapy as First-line Treatment for Advanced Malignant Pleural Mesothelioma
A Multicentre Randomised Phase III Trial Comparing Atezolizumab Plus Bevacizumab and Standard Chemotherapy Versus Bevacizumab and Standard Chemotherapy as First-line Treatment for Advanced Malignant Pleural Mesothelioma
Enrollment Status: Completed
Publish Date: July 22, 2026
Intervention Type: Drug
Study Drugs: Carboplatin, Pemetrexed, Bevacizumab, Atezolizumab
Study Phase: Phase 3
APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR Mutant NSCLC Patients
APPLE Trial: Feasibility and Activity of AZD9291 (Osimertinib) Treatment on Positive PLasma T790M in EGFR Mutant NSCLC Patients
Enrollment Status: Completed
Publish Date: June 02, 2026
Intervention Type: Drug
Study Drugs: Osimertinib, Gefitinib
Study Phase: Phase 2
View 1 Less Clinical Trial

23 Total Publications

Primary Soft Tissue Sarcomas of the Extremities: A Nationwide Retrospective Cohort Study of Histology-Specific Outcomes and Prognostic Factors.
Primary Soft Tissue Sarcomas of the Extremities: A Nationwide Retrospective Cohort Study of Histology-Specific Outcomes and Prognostic Factors.
Journal: Cancers
Published: July 06, 2026

Frequently Asked Questions about Mojca Unk

Is Mojca Unk a top-rated expert for Gastrointestinal Stromal Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Mojca Unk is classified as an Experienced expert for Gastrointestinal Stromal Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mojca Unk participate in research or clinical trials?

Yes. Mojca Unk has published 23 articles and abstracts on conditions like Gastrointestinal Stromal Tumor. You can view a list of Mojca Unk's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Unk's expertise for a condition
ConditionClose
        View All 11 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile